Martinus GijsMartin A.M. Gijs received his degree in physics in 1981 from the Katholieke Universiteit Leuven, Belgium and his Ph.D. degree in physics at the same university in 1986. He joined the Philips Research Laboratories in Eindhoven, The Netherlands, in 1987. Subsequently, he has worked there on micro-and nano-fabrication processes of high critical temperature superconducting Josephson and tunnel junctions, the microfabrication of microstructures in magnetic multilayers showing the giant magnetoresistance effect, the design and realisation of miniaturised motors for hard disk applications and the design and realisation of planar transformers for miniaturised power applications. He joined EPFL in 1997. His present interests are in developing technologies for novel magnetic devices, new microfabrication technologies for microsystems fabrication in general and the development and use of microsystems technologies for microfluidic and biomedical applications in particular.
Michel AguetDr. Michel Aguet, MD, held positions in academia and industry (Associate Professor at the Institute of Molecular Biology, University of Zürich; Head of Molecular Oncology, Genentech, So. San Francisco) before he was appointed director of the Swiss Institute for Experimental Cancer Research (ISREC) (1996-2009). In the context of the integration of ISREC into the Swiss Federal Institute of Technology (EPFL), he was appointed as Full Professor at the newly established School of Life Sciences in 2005. From 2001-2013 he directed the National Center of Competence in Research (NCCR) in Molecular Oncology, a national program launched by the Swiss National Science Foundation to encourage translational cancer research and for which ISREC was the leading house. Dr. Aguet has been a SAB member in the pharmaceutical industry, biotech industry and venture capital industry since 1997.
A large part of his scientific career was devoted to exploring the molecular biology of interferons (cloning of the interferon gamma receptor, generation of various interferon signaling mutants in the mouse) and, in collaboration with Prof. Charles Weissmann, to investigating the role of prion related protein PrP in mouse prion disease models. In recent years his research focused on characterizing the role of BCL9 proteins, which are part of the Wnt/beta-catenin transcriptional activation complex, in regulating stem cell traits in intestinal epithelium and colorectal cancer. His laboratory is now closed due to retirement.
Catherine DehollainShe got the Master Degree in Electrical Engineering in 1982 from EPFL. Then, she worked in Geneva up to 1990 as a Senior Design Engineer in telecommunications at the European research center of Motorola. From 1990 up to 1995, she did her PhD thesis at the Chaire des Circuits et Systemes at EPFL in the domain of impedance broadband matching circuits. Since 1995, she is responsible at EPFL for the RFIC group. She has participated to different Swiss research projects as well as European projects dedicated to data communication of sensors nodes (e.g. MuMoR, Minami European projects) as well as remote powering of sensor nodes. Her main domains of interest are telecom applications (e.g. Impulse radio Ultra-Wide Band, super-regenerative receivers, RFIDs)as well as biomedical applications. She has been the coordinator of European projects (e.g. FP6 SUPREGE, FP7 Ultrasponder)and of Swiss projects (e.g. CAPED CTI project, NEURO-IC SNF project).
